TACE combined with lenvatinib

DRUG2 trials

Sponsors

Second Affiliated Hospital of Guangzhou Medical University, Sun Yat-sen University

Conditions

Hepatocellular Carcinoma Non-resectableLiver Tumor

Phase 2

TACE Combined With Lenvatinib and MWA in the Treatment of Locally Advanced Large Hepatocellular Carcinoma

Sun Yat-sen UniversityLiver Tumor

Start: 2019-11-10End: 2023-11-30Target: 46Updated: 2022-09-26

Unknown Phase

TACE Plus Multikinase Inhibitor and I-125 Seeds Brachytherapy for HCC With Branch PVTT

Second Affiliated Hospital of Guangzhou Medical UniversityHepatocellular Carcinoma Non-resectable

Start: 2021-07-09End: 2025-01-08Target: 171Updated: 2023-05-18

Related Papers

A prospective single-arm phase II study of blank-microsphere transarterial chemoembolization (bTACE) plus lenvatinib (LEN) and sequential microwave ablation (MWA) in patients with large hepatocellular carcinoma (L-HCC, ≥ 7 cm): The Talem trial.

Journal of Clinical Oncology2023-01-24